PPARA and Chagas disease: Previous studies from our group showed that PPAR agonists, such as fenofibrate, a potent hypolipidemic drug, also bears anti-inflammatory properties in the context of experimental Chagas disease (Cevey et al., 2017; Rada et al., 2020).